Novo Nordisk Begins Study of Lexicon Oral Obesity Drug
The study is investigating the safety and tolerability of LX9851, how it moves through the body and its physiological and biological impacts.
Open original sourceLoading market dashboard
The study is investigating the safety and tolerability of LX9851, how it moves through the body and its physiological and biological impacts.
Open original source